Retrospective analysis of body composition in patients with cholangiocellular carcinoma (CCC) before and after transarterial radioembolization (TARE)

Retrospective analysis of body composition in patients with cholangiocellular carcinoma (CCC) before and after transarterial radioembolization (TARE) - Body Composition TARE CCC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037893

Enrollment

Registered

2025-09-12

Start date

2025-10-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with histologically confirmed cholangiocellular carcinoma (CCC) who underwent TARE C22.1

Interventions

Group 1: Retrospective Analysis of Body Composition in Patients with Cholangiocellular Carcinoma (CCC) Before and After Transarterial Radioembolization (TARE) Data Source CT datasets (abdomen and tho

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Histologically confirmed cholangiocellular carcinoma (CCC) TARE performed during the specified period at University Hospital Essen Complete documentation of pre- and post-treatment CT datasets as well as clinical follow-up data

Exclusion criteria

Exclusion criteria: Incomplete documentation or missing CT data

Design outcomes

Primary

Measure	Time frame
Overall survival (OS) from TARE Changes in body composition parameters (SI, MFI, VFI) before and after TARE	—

Secondary

Measure	Time frame
Association between body composition parameters and radiological response (mRECIST / RECIST 1.1) Incidence and severity of therapy-associated adverse events (CTCAE v5.0) Association of body composition changes with laboratory values and clinical parameters	—

Countries

Germany

Contacts

Public ContactThomas Dertnig

Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie

Thomas.Dertnig@uk-essen.de+4917641134629

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026